Before you submit your abstract, please read all of the information on this page.
Deadline: 09 July 2026 (23:59 BST)
Submit an abstract
– Presenting authors may submit an abstract for consideration in one of three categories: oral, poster or work in progress/care practice (WIP/CP) poster presentations.
– Submissions are limited to two abstracts per presenting author.
– Presenting authors are expected to attend the Symposium in-person at the RAI conference center, Amsterdam, the Netherlands.
– Presenting authors must register and accept their presentation for the Symposium before 4 September 2026 to secure attendance.
Read the full conditions of acceptance document and portal instructions before entering the submission system. We advise you to enter the abstract submission system well in advance of the deadline to ensure any difficulties can be resolved in time.
Process:
- Begin by creating a new account using the presenting author's email address.
- Select a theme that best matches your abstract from the list, this may be changed by the programme committee.
- Add all authors and affiliations in the correct order checking spelling.
- Submit an abstract (max 450 words) in the abstract submission portal in advance of the deadline.
By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
To withdraw your abstract please email abstracts@mndassociation. Withdrawals must be made before 4 September to be withdrawn from the journal supplement.
Proposed poster themes
- Epidemiology and Informatics (EPI)
- Genetics and genomics (GEN)
- In vitro experimental models (IVT)
- In vivo experimental models (IVV)
- Human cell biology and pathology (HCB)
- Tissue biomarkers (BIO)
- Pre-clinical therapeutic strategies (TST)
- Clinical imaging and electrophysiology (IMG)
- Clinical trials and trial design (CLT)
- Disease stratification and phenotyping of patients (DSP)
- Cognitive and psychological assessment and support (COG)
- Clinical management and support (CMS)
Next steps: Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. Decision emails will be sent to the registered email address in August and you will be asked to register to accept your place. Further instructions of presentation timings and how to submit your poster material (PDF) will be emailed from September (see key dates below).
*Refunds can be made available in the event that you no longer wish to attend due to an abstract being rejected. Please see Symposium registration T&Cs for more information.
Presenter Registration
If you are submitting an abstract, please use the registration link within the abstract portal by 4 September 2026.
Failure to register by 4 September will result in the withdrawal of your abstract
Key dates
| Abstract submission opens | 5 May 2026 |
| Abstract submission deadline | 9 July 2026 (23:59 UK time) |
| Notification of abstract decision | August 2026 |
| Withdrawal deadline | 4 September 2026 (23:59 UK time) |
| Poster submission (PDF) opens | 12 September 2026 |
| Poster submission (PDF) deadline | 16 November 2026 (23:59 UK time) |
| Abstract book published on website | Early November 2026 |
| Symposium | 9–11 December 2026 |
You can sign up for regular Symposium updates by subscribing to our mailing list Symposium updates or contacting symposium@mndassociation.org so that you don't miss any important dates and announcements.
If you have any specific abstract-related queries please email abstracts@mndassociation.org.
Abstract Submission Information and FAQs
Authors will be asked to assign a theme to their abstract in the abstract submission portal. The themes are as follows:
- Epidemiology and Informatics (EPI)
- Genetics and genomics (GEN)
- In vitro experimental models (IVT)
- In vivo experimental models (IVV)
- Human cell biology and pathology (HCB)
- Tissue biomarkers (BIO)
- Pre-clinical therapeutic strategies (TST)
- Clinical imaging and electrophysiology (IMG)
- Clinical trials and trial design (CLT)
- Disease stratification and phenotyping of patients (DSP)
- Cognitive and psychological assessment and support (COG)
- Clinical management and support (CMS)
Submissions are limited to two abstracts per presenting author.
Authors do not need to register before submitting an abstract however we do recommend registering and applying for a VISA as early as possible. Refunds will be available in the event of an abstract being rejected.
Presenting authors will be required to pay the appropriate in-person registration fee by 4 September or their abstract will be withdrawn. Formal acceptance of an abstract is conditional upon payment of the full registration fee.
Abstracts will be published in an online open access supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This abstract book will be published online on the Taylor and Francis website and will be found via the Symposium website (symposium.mndassociation.org). Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website.
By submitting an abstract, you consent to give us the license to act on your behalf with the Taylor & Francis group to publish your abstract in the symposium supplement of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
WIP/CP stands for work in progress/care practice. WIP/CP is defined as: preliminary work (little or no data/results), care practice or case studies.
Yes, abstracts may be submitted even if previously presented at a national/international meeting.
Once the submission deadline has passed, abstracts will be reviewed by the Symposium Programme Committee. We will inform you of the decision in August and if you have been accepted. Presenters who have accepted their presentation slot and registered before 6 September will get a second notification in September which will include specific presentation theme/session, time and date information. Oral presenters will receive a document to help create slides. Poster presenters will receive details and instructions on poster guidelines and how to submit their poster material (poster PDF) to our virtual platform for our virtual delegates before the upload deadline of 16 November 2026.